Author
Stanford MedicineORCID 0000-0002-9124-3192Unclaimed ORCID profile · follow to get notified of new preprints
6 papers
Recent·Most cited
Keren M. Adler, Haiqing Xu, Amy C. Gladstein…·David M. Feldser
This study shows tumor suppressor genotype affects immune cell recruitment and tumor growth in KRAS-driven lung cancer with varying neoantigen expression.
Yuexuan Long, Xiaolin Ni, Ting-Wei Chen…·Erping Long
The paper identifies genetic determinants of gene expression noise and links them to complex trait variation using a large-scale human blood cell dataset.
Yuning J. Tang, Haiqing Xu, Nicholas W. Hughes…·Monte M. Winslow
The paper identifies HBO1 and MLL1 complexes as key tumor suppressors in lung cancer using in vivo functional screens of epigenetic regulators.
Jess D. Hebert, Haiqing Xu, Yuning J. Tang…·Monte M. Winslow
This study develops transgenic Cas12a mice to enable efficient, multiplexed somatic genome editing for studying complex genetic interactions in vivo.
Anthony M. Boutelle, Aicha R. Mabene, David Yao…·Laura Donatella Attardi
The paper identifies ZMAT3 and CDKN1A as key hubs in the p53 tumor suppression network through integrative multiomic analyses in a mouse model.
Emily L. Ashkin, Yuning J. Tang, Haiqing Xu…·Monte M. Winslow
This study identifies a STAG2-PAXIP1/PAGR1 tumor-suppressive axis in lung cancer by showing their combined role in suppressing oncogenic KRAS-driven tumorigenesis.